Published in Br J Ophthalmol on October 29, 2013
Ophthalmic Metastasis of Breast Cancer and Ocular Side Effects from Breast Cancer Treatment and Management: Mini Review. Biomed Res Int (2015) 0.79
Retinal and vitreous metastases from hepatocholangiocarcinoma. BMC Cancer (2017) 0.76
Visual impairment due to bilateral multifocal choroidal metastasis of parotid adenocarcinoma: a case report. Front Oncol (2014) 0.76
The effect of intravitreal bevacizumab and transpupillary thermotherapy on choroidal metastases and literature review. Indian J Ophthalmol (2015) 0.75
Alveolar Rhabdomyosarcoma of the foot metastasizing to the Iris: report of a rare case. BMC Cancer (2016) 0.75
Diagnostic vitrectomy for infectious uveitis. Int Ophthalmol Clin (2014) 0.75
Retinal detachment after phacoemulsification in high myopia: analysis of 2356 cases. J Cataract Refract Surg (2008) 2.30
Understanding intraocular lymphomas. Clin Experiment Ophthalmol (2008) 2.23
Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist (2011) 2.05
Single nucleotide polymorphism array analysis of uveal melanomas reveals that amplification of CNKSR3 is correlated with improved patient survival. Am J Pathol (2013) 2.02
Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res (2010) 1.80
Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol (2011) 1.78
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site. J Immunol (2006) 1.74
Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology (2007) 1.68
Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol (2004) 1.29
A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology (2004) 1.27
Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci (2009) 1.25
Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification. Invest Ophthalmol Vis Sci (2010) 1.23
Epithelial tumours of the lacrimal gland: a clinical, histopathological, surgical and oncological survey. Acta Ophthalmol (2012) 1.22
Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial. Graefes Arch Clin Exp Ophthalmol (2005) 1.22
Concentric retinal pigment epithelium atrophy after a single photodynamic therapy. Graefes Arch Clin Exp Ophthalmol (2003) 1.16
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2010) 1.14
Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab. Am J Ophthalmol (2010) 1.14
Long-term outcome of primary endoresection of choroidal melanoma. Br J Ophthalmol (2013) 1.13
Lymphomas involving the eye and the ocular adnexa. Curr Opin Ophthalmol (2006) 1.10
Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology (2008) 1.09
Molecular analysis of uveal melanoma. Ophthalmology (2013) 1.08
Transretinal choroidal tumor biopsy with a 25-gauge vitrector. Ophthalmology (2006) 1.08
Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol (2003) 1.06
Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes. Invest Ophthalmol Vis Sci (2011) 1.06
Correspondence. Retina (2013) 1.06
Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Experiment Ophthalmol (2008) 1.06
Translating uveal melanoma cytogenetics into clinical care. Arch Ophthalmol (2009) 1.05
Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res (2011) 1.05
Ca2+ channels in retinal pigment epithelial cells regulate vascular endothelial growth factor secretion rates in health and disease. Mol Vis (2007) 1.04
A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years. Am J Ophthalmol (2011) 1.00
Retrospective review of 50 eyes with long-term silicone oil tamponade for more than 12 months. Graefes Arch Clin Exp Ophthalmol (2011) 1.00
Implantation of scleral fixated sutured posterior chamber lenses: a retrospective analysis of 119 cases. Int Ophthalmol (2008) 0.99
Primary vitrectomy versus scleral buckling for the treatment of rhegmatogenous retinal detachment: a meta-analysis of randomized controlled clinical trials. Curr Eye Res (2012) 0.99
Retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: long-term results. Graefes Arch Clin Exp Ophthalmol (2007) 0.99
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): predictive factors for functional outcome. Study report no. 6. Graefes Arch Clin Exp Ophthalmol (2011) 0.97
Endophthalmitis following intravitreal injections. Graefes Arch Clin Exp Ophthalmol (2011) 0.96
Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Ophthalmology (2008) 0.95
Low-grade primary central nervous system lymphoma in immunocompetent patients. Br J Haematol (2005) 0.94
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR study): Risk assessment of anatomical outcome. SPR study report no. 7. Acta Ophthalmol (2012) 0.94
Primary 23-gauge sutureless vitrectomy for rhegmatogenous retinal detachment. Indian J Ophthalmol (2012) 0.94
Does the presence of an epiretinal membrane alter the cleavage plane during internal limiting membrane peeling? Ophthalmology (2009) 0.94
Spontaneous progressive supra-choroidal haemorrhage in a patient undergoing haemodialysis. Graefes Arch Clin Exp Ophthalmol (2007) 0.93
Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis. Oncol Rep (2008) 0.93
A TNM-based clinical staging system of ocular adnexal lymphomas. Arch Pathol Lab Med (2009) 0.92
Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol (2014) 0.92
Uveal melanoma cell lines contain stem-like cells that self-renew, produce differentiated progeny, and survive chemotherapy. Invest Ophthalmol Vis Sci (2011) 0.92
Management of conjunctival melanoma. Expert Rev Anticancer Ther (2009) 0.91
Atrophy of the retinal pigment epithelium following vitrectomy with trypan blue. Int Ophthalmol (2008) 0.91
Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma. Invest Ophthalmol Vis Sci (2012) 0.91
Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study. Ophthalmology (2003) 0.90
Incidence and outcome of endophthalmitis over a 13-year period. Can J Ophthalmol (2009) 0.89
Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. Am J Clin Pathol (2007) 0.89
MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. Br J Ophthalmol (2012) 0.89
Cancer of the orbit and adnexa. Am J Clin Oncol (2013) 0.89
Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol (2013) 0.89
Management of traumatic posterior capsular rupture: corneal approach with high speed vitrector. J Cataract Refract Surg (2005) 0.88
GDF-15: a novel serum marker for metastases in uveal melanoma patients. Graefes Arch Clin Exp Ophthalmol (2011) 0.88
P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma. J Cell Mol Med (2009) 0.88
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): recruitment list evaluation. Study report no. 2. Graefes Arch Clin Exp Ophthalmol (2006) 0.88
Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. Exp Eye Res (2006) 0.87
Proteomic analyses of the vitreous humour. Mediators Inflamm (2012) 0.87
Choroidal metastasis from primary pulmonary leiomyosarcoma. Clin Experiment Ophthalmol (2011) 0.87
Bilateral vasoproliferative retinal tumors with identical localization in a pair of monozygotic twins. Arch Ophthalmol (2002) 0.87
Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms. Pathol Oncol Res (2014) 0.87
Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest Ophthalmol Vis Sci (2010) 0.86
Choroidal melanoma endoresection, dandelions and allegory-based medicine. Br J Ophthalmol (2008) 0.86
IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas. Graefes Arch Clin Exp Ophthalmol (2012) 0.85
Fibrous membranes in diabetic retinopathy and bevacizumab. Retina (2010) 0.85
Association of tissue-factor upregulation in squamous-cell carcinoma of the lung with increased tissue factor in circulating blood. Lancet Oncol (2005) 0.84
Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Invest Ophthalmol Vis Sci (2009) 0.84
HSP-27 protein expression in uveal melanoma: correlation with predicted survival. Acta Ophthalmol (2010) 0.84
Photodynamic therapy with verteporfin for choroidal neovascularisations in clinical routine outside the TAP study. One- and two-year results including juxtafoveal and extrafoveal CNV. Graefes Arch Clin Exp Ophthalmol (2004) 0.84
Early multifocal electroretinogram findings during intravitreal ranibizumab treatment for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.83
Long-term results after surgical extraction of subfoveal choroidal neovascular membranes with and without haemorrhage in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2004) 0.83
The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells. Cell Growth Differ (2002) 0.83
Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type. Arch Ophthalmol (2011) 0.83
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR study): multiple-event analysis of risk factors for reoperations. SPR Study report no. 4. Acta Ophthalmol (2009) 0.83
Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma. Graefes Arch Clin Exp Ophthalmol (2012) 0.83
What pressure is exerted on the retina by heavy tamponade agents? Graefes Arch Clin Exp Ophthalmol (2004) 0.83
Immunohistochemical assessment of mitotic count in uveal melanoma. Acta Ophthalmol (2011) 0.83
Multiplex ligation-dependent probe amplification analysis of uveal melanoma with extraocular extension demonstrates heterogeneity of gross chromosomal abnormalities. Invest Ophthalmol Vis Sci (2011) 0.83
Differential expression of angioregulatory matricellular proteins in posterior uveal melanoma. Melanoma Res (2005) 0.82
Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height. Graefes Arch Clin Exp Ophthalmol (2006) 0.82
Whole anterior segment proton beam radiotherapy for diffuse iris melanoma. Br J Ophthalmol (2013) 0.82
Can the sequential use of conventional silicone oil and heavy oil be a strategy for the management of proliferative vitreoretinopathy? Ann Acad Med Singapore (2006) 0.82
Reconciling the principle of patient autonomy with the practice of informed consent: decision-making about prognostication in uveal melanoma. Health Expect (2010) 0.81
Extraocular extension of uveal melanoma after fine-needle aspiration, vitrectomy, and open biopsy. JAMA Ophthalmol (2013) 0.81
Baerveldt implant for secondary glaucoma due to iris melanoma. Clin Ophthalmol (2010) 0.81
Exposure of orbital implants wrapped with polyester-urethane after enucleation for advanced retinoblastoma. Ophthal Plast Reconstr Surg (2005) 0.81
Status of RASSF1A in uveal melanocytes and melanoma cells. Mol Cancer Res (2011) 0.81
Iridocyclectomy for neovascular glaucoma caused by proton-beam radiotherapy of pigmented ciliary adenocarcinoma. Graefes Arch Clin Exp Ophthalmol (2008) 0.81